Substituted aryloximes

Details Substituted aryloximes Substituted aryloximes

2008-09-02

2008-09-02

Kumar, Shailendra (Department: 1621)

Organic compounds -- part of the class 532-570 series

Organic compounds

Carboxylic acids and salts thereof

C514S568000, C514S570000

Reexamination Certificate

active

10948611

ABSTRACT:
The present invention relates to substituted aryl oximes and methods of using them.

REFERENCES:
patent: 3026325 (1962-03-01), Heinzelman et al.
patent: 3476770 (1969-11-01), Scherrer
patent: 3557142 (1971-01-01), Bell
patent: 3843683 (1974-10-01), Bell
patent: 4478819 (1984-10-01), Hercelin et al.
patent: 4736043 (1988-04-01), Michel et al.
patent: 4851406 (1989-07-01), Mertens et al.
patent: 5164372 (1992-11-01), Matsuo et al.
patent: 5393920 (1995-02-01), Benoit et al.
patent: 5420289 (1995-05-01), Musser et al.
patent: 5482960 (1996-01-01), Berryman
patent: 5502187 (1996-03-01), Ayer et al.
patent: 5541343 (1996-07-01), Himmelsbach et al.
patent: 5599663 (1997-02-01), Vaughan
patent: 5612360 (1997-03-01), Boyd et al.
patent: 5859044 (1999-01-01), Dow et al.
patent: 6048875 (2000-04-01), De Nanteuil et al.
patent: 6054621 (2000-04-01), Gayer et al.
patent: 6103907 (2000-08-01), Yanagisawa et al.
patent: 6110963 (2000-08-01), Malamas
patent: 6166069 (2000-12-01), Malamas et al.
patent: 6177463 (2001-01-01), Gerdes et al.
patent: 6194464 (2001-02-01), Kuhnt et al.
patent: 6221865 (2001-04-01), Sebti et al.
patent: 6232322 (2001-05-01), Malamas et al.
patent: 6251936 (2001-06-01), Wrobel et al.
patent: 6302837 (2001-10-01), De Nanteuil et al.
patent: 6479524 (2002-11-01), Priepke et al.
patent: 6599929 (2003-07-01), Cho et al.
patent: 6787556 (2004-09-01), Hargreaves et al.
patent: 6800645 (2004-10-01), Cox et al.
patent: 6800654 (2004-10-01), Mayer et al.
patent: 6844358 (2005-01-01), Malamas et al.
patent: 2003/0013732 (2003-01-01), Elokdah
patent: 2003/0018067 (2003-01-01), Elokdah et al.
patent: 2003/0060497 (2003-03-01), Gerlach et al.
patent: 2003/0125371 (2003-07-01), Elokdah et al.
patent: 2004/0116488 (2004-06-01), Jennings et al.
patent: 2004/0116504 (2004-06-01), Elokdah et al.
patent: 2004/0122070 (2004-06-01), Jennings
patent: 2004/0138283 (2004-07-01), Jennings et al.
patent: 2004/0204417 (2004-10-01), Perez et al.
patent: 2005/0070585 (2005-03-01), Elokdah et al.
patent: 2005/0070587 (2005-03-01), Elokdah et al.
patent: 2005/0070592 (2005-03-01), Gundersen
patent: 2005/0096377 (2005-05-01), Hu
patent: 2005/0113428 (2005-05-01), Gopalsamy et al.
patent: 2005/0113436 (2005-05-01), Elokdah et al.
patent: 2005/0113438 (2005-05-01), Hu et al.
patent: 2005/0113439 (2005-05-01), Hu
patent: 2005/0119296 (2005-06-01), Elokdah et al.
patent: 2005/0119326 (2005-06-01), Havran et al.
patent: 2005/0119327 (2005-06-01), Hu
patent: 2005/0215626 (2005-09-01), Havran et al.
patent: 2007/0167490 (2007-07-01), Ishida et al.
patent: 3147276 (1981-11-01), None
patent: 43 38 770 (1995-05-01), None
patent: 19543639 (1997-05-01), None
patent: 19753522 (1999-06-01), None
patent: 0 416 609 (1991-03-01), None
patent: 0 508 723 (1992-10-01), None
patent: 0 512 570 (1992-11-01), None
patent: 0 540 956 (1993-05-01), None
patent: 0 564 984 (1993-10-01), None
patent: 0 655 439 (1995-05-01), None
patent: 0 759 434 (1997-02-01), None
patent: 0 819 686 (1998-01-01), None
patent: 0 822 185 (1998-02-01), None
patent: 708 098 (1999-03-01), None
patent: 0 916 651 (1999-05-01), None
patent: 0 955 299 (1999-11-01), None
patent: 1 092 716 (2001-04-01), None
patent: 1 156 045 (2001-11-01), None
patent: 1 354 602 (2003-10-01), None
patent: 2 244 499 (1975-04-01), None
patent: 2 777 886 (1999-10-01), None
patent: 2 799 756 (2001-04-01), None
patent: 1 321 433 (1973-06-01), None
patent: 7-41459 (1995-02-01), None
patent: 11-193272 (1999-07-01), None
patent: 2000-344748 (2000-12-01), None
patent: 96/21656 (1986-07-01), None
patent: 94/13637 (1994-06-01), None
patent: 94/14434 (1994-07-01), None
patent: 94/26738 (1994-11-01), None
patent: 95/10513 (1995-04-01), None
patent: WO 95/24383 (1995-09-01), None
patent: WO 95/29907 (1995-11-01), None
patent: 96/06840 (1996-03-01), None
patent: WO 96/07636 (1996-03-01), None
patent: 96/26207 (1996-08-01), None
patent: WO 96/32379 (1996-10-01), None
patent: WO 97/07096 (1997-02-01), None
patent: 97/09308 (1997-03-01), None
patent: WO 97/37970 (1997-10-01), None
patent: 97/43260 (1997-11-01), None
patent: 97/48697 (1997-12-01), None
patent: 98/08818 (1998-03-01), None
patent: WO 98/50029 (1998-11-01), None
patent: 99/28297 (1999-06-01), None
patent: 99/43672 (1999-09-01), None
patent: 99/46260 (1999-09-01), None
patent: WO 99/43651 (1999-09-01), None
patent: WO 99/43654 (1999-09-01), None
patent: 99/50268 (1999-10-01), None
patent: 99/58519 (1999-11-01), None
patent: 99/61435 (1999-12-01), None
patent: 00/32180 (2000-06-01), None
patent: 0/35919 (2000-06-01), None
patent: 00/46195 (2000-08-01), None
patent: 00/46197 (2000-08-01), None
patent: 00/64876 (2000-11-01), None
patent: 00/64888 (2000-11-01), None
patent: 01/12187 (2001-02-01), None
patent: WO 02/24633 (2002-03-01), None
patent: 02/030895 (2002-04-01), None
patent: 02/072549 (2002-09-01), None
patent: 03/000253 (2003-01-01), None
patent: 03/031409 (2003-04-01), None
patent: 03/068742 (2003-08-01), None
patent: 03/087087 (2003-10-01), None
patent: 2004/052854 (2004-06-01), None
patent: WO 2004/080947 (2004-09-01), None
Krishnamurti, C. et al., “Plasminogen Activator Inhibitor: A Regulator of Ancrod-Induced Fibrin Deposition in Rabbits,”Blood, 69(3): 798-803 (Mar. 1987).
Reilly, C. et al., “Both Circulating and Clot-Bound Plasminogen Activator-1 Inhibit Endogenous Fibrinolysis in the Rat,”Arteriosclerosis and Thrombosis, 11(5): 1276-1286 (Sep./Oct. 1991).
Carmeliet, P. et al., “Plasminogen Activator Inhibitor-1 Gene-deficient Mice,”Journal of Clinical Investigation, 92: 2756-2760 (Dec. 1993).
Rocha, E. et al., “The Relationship Between Impaired Fibrinolysis and Coronary Heart Disease,”Fibrinolysis, 8: 294-303 (1994).
Aznar, J. et al., “Role of Plasminogen Activator Inhibitor Type 1 in the Pathogenesis of Coronary Artery Diseases,”Haemostasis24: 243-251 (1994).
Biemond, B. J. et al., “Thrombolysis and Reocclusion in Experimental Jugular Vein and Coronary Artery Thrombosis,”Circulation, 91: 1175-1181 (1995).
Levi, M. et al., “Inhibition of Plasminogen Activator Inhibitor-1 Activity Results in Promotion of Endogenous Thrombolysis and Inhibition of Thrombus Experimental Thrombosis,”Circulation85:305-312 (1992).
Nordt, T. K. et al., “Differential Regulation by Troglitazone of Plasminogen Activator Inhibitor Type 1 in Human Hepatic and Vascular Cells,”Journal of Clinical Endocrinology and Metabolism, 85(4):1563-1568 (2000).
Daci, E. et al., “Mice Lacking the Plasminogen Activator Inhibitor 1 are Protected from Trabecular Bone Loss Induced by Estrogen Deficiency,”Journal of Bone and Mineral Research, 15(8):1510-1516 (Nov. 8, 2000).
Schneiderman J. et. al., “Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries,”Proc Natl Acad Sci89: 6998-7002 (Aug. 1992).
Juhan-Vague, I. et. al., “Deficient t-PA Release and Elevated PA Inhibitor Levels in Patients with Spontaneous or Recurrent Deep Venous Thrombosis,”Thromb Haemost57: 67-72 (1987).
Juhan-Vague, I. et. al., “PAI-1, Obesity, Insulin Resistance and Risk of Cardiovascular Events,”Thromb Haemost78: 565-660 (1997).
Hamsten, A. et. al., “Plasminogen Activator Inhibitor in Plasma: Risk Factor For Recurrent Myocardial Infarction,”Lancet2: 3-9 (Jul. 4, 1987).
Siemens, H. J. et. al., “Course of Molecular Hemostatic Markers During and After Different Surgical Procedures,”J Clin Anesthesia11: 622-629 (Dec. 1999).
Koh, K. et. al., “Effects of Hormone-Replacement Therapy on Fibrinolysis in Postmenopausal Women,”N Engl J Med336(10): 683-690 (Mar. 6, 1997).
Ley, J. P. et al., “Hydroxy- or Methoxy-Substituted Benzaldoximes and Benzaldehyde-O-alkyloximes as Tyrosinase Inhibitors,”Bioorganic&Medicinal Chemistry, 2001, 9:1879-1885.
Yoshikawa, H. et al., “Benzaldehyde O-Alkyloximes as New Plant Growth Regulators,”BioSci. Biotechnol. Biochem., 62(5), pp. 996-997, 1998.
Yoshikawa, H. et al., “Synthesis an

Affiliated with

Also associated with

Rating

Substituted aryloximes does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Substituted aryloximes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted aryloximes will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3919293